Unraveling Immune Mechanisms in Reproductive Health – Reproduction and Fertility
Reproduction and Fertility shared a post on LinkedIn:
“Day 2 of RaFJC – Immune Adaptation from Conception to Pregnancy
After exploring how ovulation itself is an immune‑regulated event, with inflammatory mediators shaping oocyte release and follicle competence, today we move forward in the reproductive timeline: conception and implantation: immune cross-talk determines whether the embryo is accepted or rejected.
Immune and Inflammatory Responses at Implantation
- During differentiation, the blastocyst expresses L-selectins (a cell adhesion molecule that facilitates the initial ‘tethering’ and ‘rolling’ of leukocytes. L-selectins interact with L-selectin ligands, which are expressed mainly on pinopodes during the implantation window.
- During apposition and the adhesion phase, the blastocyst promotes cleavage of Mucin-1, which drives the implantation window and ensures successful attachment. Cytokines such as Leukemia inhibitory factor (LIF) play an important role during human implantation by supporting the embryo-endometrial interactions.
- During the invasion phase, the trophoblast cells penetrate the endometrial epithelium into the stroma. The extra-villous trophoblast cells proliferate and differentiate into inner cytotrophoblast and outer syncytiotrophoblast.
- When implantation begins, the embryo breaches the luminal epithelium, and the surrounding stromal cells transform into decidual cells. Immune cells, such as macrophages and uterine natural killer (uNK) cells, play an important role during decidualization by promoting an environment conducive to successful implantation.
Dysregulation of these pathways is linked to implantation failure, recurrent miscarriage, and pregnancy complications.
Implantation is not passive! It’s an immune dialogue between the embryo and the endometrium. Understanding this dialogue is critical for improving fertility treatments and predicting pregnancy outcomes.
What immune mechanisms at implantation deserve more attention in reproductive medicine? How can we better translate these findings into clinical practice? We would love to hear your thoughts in the comments.
Are you interested in this topic? Explore our next Serial Collection: Immune Regulation and Inflammatory Mechanisms in Reproductive Health and Disease, and submit your article to be a part of it.
Tomorrow we’ll be extending this discussion into pregnancy and delivery, highlighting maternal immune adaptations – stay tuned!”

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 28, 2026, 15:55Katy Encalade: What Are the Biggest Myths About Egg Donation?
-
Oct 28, 2026, 15:53Diana Kayal: A Free Webinar on Trauma, Infertility and the Patient Journey
-
Oct 28, 2026, 15:49Rebecca Watson O’Connor: Applications for the 2027 PRIMED Cohort Are Open
-
Oct 28, 2026, 15:45Martin Varsavsky: Gameto Has Been Acquired by Ferring for 1.38 Billion Dollars
-
Oct 28, 2026, 15:37Gili Band: The People Are What Stay With Me After Day 1 at ASRM 2026
-
Oct 28, 2026, 13:56Samantha Payne: NSW Releases Final Report on Fertility Support and Assisted Reproductive Treatment
-
Oct 28, 2026, 13:53True Friendship and PCOS: Why Emotional Support Matters – PCOS Millennials
-
Oct 28, 2026, 13:51Fred Ushakov: The Future of Prenatal Screening, The Future of Your Practice
-
Oct 28, 2026, 13:49Hosting the First-Ever Fairfax Awards – Fairfax EggBank
